Am. J. Respir. Crit. Care Med., Vol 149, No. 3, Mar 1994, 788-794.
Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients
C Cordonnier, J Fleury-Feith, E Escudier, K Atassi and JF Bernaudin
Department of Clinical Hematology, Hopital Henri Mondor, Creteil, France.
We report here our experience of secondary pulmonary alveolar proteinosis
(PAP) in patients with hematologic malignancies. The diagnosis of PAP was
made by bronchoalveolar lavage (BAL) and based on the identification of
periodic acid-Schiff-positive proteinaceous material with the
characteristic ultrastructural pattern. Ten patients with leukemia and
secondary PAP are described. Three patients had received bone marrow
transplants. Data obtained from sequential BAL have shown that at least
four of them--all of them achieving complete remission or recovery from
neutropenia after bone marrow transplantation--had reversible PAP, and we
emphasize this potential reversibility. Furthermore, in order to estimate
the frequency of PAP in hematologic patients, we retrospectively studied
113 episodes of pneumonia occurring in our department over a 2-yr period.
The incidence of secondary PAP in patients with pulmonary symptoms was so
estimated at 5.3% among all the hematologic population, and to 10% in
patients with myeloid disorders. This report (1) confirms that BAL is an
accurate way to diagnose PAP in immunocompromised hosts, (2) emphasizes
that PAP is not an unusual cause of respiratory failure in this population
and that it is strongly associated with myeloid disorders, and (3) shows
that secondary PAP is potentially reversible, especially if complete
remission of the underlying disease is achieved.
This article has been cited by other articles:

|
 |

|
 |
 
O C Ioachimescu and M S Kavuru
Pulmonary alveolar proteinosis
Chronic Respiratory Disease,
July 1, 2006;
3(3):
149 - 159.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bush
Paediatric interstitial lung disease: not just kid's stuff
Eur. Respir. J.,
October 1, 2004;
24(4):
521 - 523.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Trapnell, J. A. Whitsett, and K. Nakata
Pulmonary Alveolar Proteinosis
N. Engl. J. Med.,
December 25, 2003;
349(26):
2527 - 2539.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-L. Cheng, P.-H. Kuo, P.-C. Yang, and K.-T. Luh
Bilateral Alveolar Infiltrates in a 29-Year-Old Man With Chronic Myelogenous Leukemia
Chest,
December 1, 2002;
122(6):
2238 - 2241.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Seymour and J. J. Presneill
Pulmonary Alveolar Proteinosis: Progress in the First 44 Years
Am. J. Respir. Crit. Care Med.,
July 15, 2002;
166(2):
215 - 235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Khurshid and L C Anderson
Non-infectious pulmonary complications after bone marrow transplantation
Postgrad. Med. J.,
May 1, 2002;
78(919):
257 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-W. Chou, F.-C. Lin, S.-M. Tung, R.-D. Liou, and S.-C. Chang
Diagnosis of Pulmonary Alveolar Proteinosis: Usefulness of Papanicolaou-Stained Smears of Bronchoalveolar Lavage Fluid
Arch Intern Med,
February 26, 2001;
161(4):
562 - 566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mayaud and J. Cadranel
A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host
Thorax,
June 1, 2000;
55(6):
511 - 517.
[Full Text]
|
 |
|

|
 |

|
 |
 
P. L Shah, D. Hansell, P. R Lawson, K. B M Reid, and C. Morgan
Rare diseases bullet 6: Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis
Thorax,
January 1, 2000;
55(1):
67 - 77.
[Full Text]
|
 |
|
Copyright © 1994 American Thoracic Society
|
|
|